Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Practice Utility Study to Assess DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years

NCT04563949 is registered in ClinicalTrials.gov with DermTech as lead sponsor.

NCT NCT04563949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04563949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Practice Utility Study to Assess DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years
Lead sponsor
DermTech
Phase
Observational
Overall status
Completed
Start date
November 16, 2017
Completion date
December 15, 2020
Enrollment
323 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma detection